Clinical Trial Update: Umbilical Cord Blood NK Cell Therapy for High-Risk Pediatric Soft Tissue Sarcoma: Efficacy and Safety Study [NA]

View source ↗

Summary

This clinical trial update reports on a study of umbilical cord blood-derived natural killer (NK) cell therapy for high-risk pediatric soft tissue sarcoma, curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Umbilical cord blood-derived natural killer (NK) cell therapy (umbilical cord blood NK cells)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Soft Tissue Sarcoma (STS) | NA | Status: RECRUITING